Safety, Tolerability, and Pharmacokinetics of ACT500 in Healthy Adult Participants

NCT06716905 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-alcoholic Steatohepatitis

Interventions

DRUG: ACT500 tablets
DRUG: Placebo
DRUG: ACT500 tablets
DRUG: Placebo

Sponsor

Xiamen Amoytop Biotech Co., Ltd.

Collaborators

[object Object]